Skip to main content

Table 1 Patients’ baseline profiles (N = 40)

From: Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease

  Saxagliptin Mitiglinide P value
Number 20 20
Female (n) 2 5 0.4075
Age 68.6 ± 10.1 63.0 ± 13.1 0.1288
BMI 22.5 ± 2.7 24.2 ± 3.5 0.0973
HD dulation (months) 42.8 ± 36.3 70.4 ± 58.2 0.0745
DM dulation (years) 14.5 ± 6.2 15.7 ± 7.4 0.5853
Acarbose (mg/day) 225.0 ± 82.2 187.5 ± 69.4 0.3728
Voglibose (mg/day) 0.75 ± 0.16 0.66 ± 0.13 0.3527
Mitiglinide (mg/day) 16.9 ± 5.3 15.0 ± 0.0 0.4082
Glimepiride (mg/day) 0.50 ± 0.0
HbA1c (%) 6.0 ± 0.9 6.3 ± 1.4 0.5219
GA (%) 19.2 ± 3.2 18.9 ± 4.4 0.8372
BUN (mg/dL) 59.7 ± 11.9 64.4 ± 14.6 0.2724
Cr (mg/dL) 9.36 ± 2.63 10.81 ± 3.47 0.1396
UA (mg/dL) 5.8 ± 1.4 6.5 ± 1.5 0.1427
Na (mEq/L) 133.9 ± 2.2 138.4 ± 2.7 0.384
K (mEq/L) 5.0 ± 0.7 4.7 ± 0.7 0.1736
Cl (mEq/L) 107.3 ± 3.3 95.0 ± 3.2 0.0898
Ca (mg/dL) 8.2 ± 0.4 8.6 ± 0.7 0.0285
P (mg/dL) 5.1 ± 1.0 5.4 ± 1.1 0.246
TP (g/dL) 6.8 ± 0.5 6.7 ± 0.4 0.5831
Glu (mg/dL) 163.0 ± 59.8 158.2 ± 55.9 0.7934
AST (U/L) 13.9 ± 6.1 11.5 ± 5.2 0.2023
ALT (U/L) 10.3 ± 5.4 9.8 ± 4.6 0.7818
LDH (U/L) 208.4 ± 45.8 179.7 ± 44.3 0.0515
ALP (U/L) 238.5 ± 68.2 256.3 ± 146.5 0.6199
GTP (U/L) 34.5 ± 78.2 23.3 ± 14.1 0.5437
iPTH (pg/mL) 191.0 ± 101.3 204.2 ± 151.0 0.7457
  1. BMI body mass index, HD hemodialysis, DM diabetes mellitus, HbA1c hemoglobin A1c, GA glycated albumin, BUN blood urea nitrogen, Cr creatinine, UA uric acid, TP total protein, Glu glucose, AST aspartate aminotransferase, ALT alanine aminotransferase, GTP γ-glutamyl transpeptidase, iPTH intact parathyroid hormone